Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, retail drugstore operator Rite Aid (RAD +0.00%) has received the dreaded one-star ranking.
With that in mind, let's take a closer look at Rite Aid and see what CAPS investors are saying about the stock right now.
Rite Aid facts
|
Headquarters (Founded) |
Camp Hill, Pa. (1927) |
|
Market Cap |
$944.4 million |
|
Industry |
Drug retail |
|
Trailing-12-Month Revenue |
$26.2 billion |
|
Management |
Chairman/CEO John Standley |
|
Return on Capital (Average, Past 3 Years) |
4% |
|
Cash/Debt |
$94.3 million / $6.2 billion |
|
Competitors |
CVS Caremark (CVS +1.07%) |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 17% of the 979 members who have rated Rite Aid believe the stock will underperform the S&P 500 going forward.
Just last week, one of those bulls, PrototypeZ, brought a few of Rite Aid's worrisome stats to our community's attention:
Debt > $6B Dollars
No profit
Operating Margin ~1%
Shrinking Sales
Burning CashBankruptcy candidate, liquidation
If you want market-topping returns, you need to protect your portfolio from any undue risk. Luckily, we've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2013." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
